Sign In
Search Icon
Menu Icon

Implementation Approach

The National Influenza Vaccine Modernization Task Force (Task Force) is co-chaired by the Department of Health and Human Services (HHS) and the Department of Defense (DoD). The HHS Assistant Secretary for Preparedness and Response and the DoD Assistant Secretary of Defense for Health Affairs have been designated by their respective Secretaries to coordinate implementation of the NIVMS, monitor progress, and make course corrections, as needed. The Task Force will bring together key interagency partners, including senior leadership from HHS, DoD, Department of Justice, U.S. Department of Agriculture, Department of Veterans Affairs, Department of Homeland Security, and other federal partners. The Task Force will also engage non-federal entities such as SLTT governments, health care stakeholders, academia, private industry, non-governmental organizations, and international stakeholders, as appropriate.


National Influenza Vaccine Modernization Task Force

  • Department of Health and Human Services
    • Assistant Secretary for Preparedness and Response (ASPR)(Co-Chair)
      • Biomedical Advance Research and Development Authority (BARDA)
    • Center for Disease Control and Prevention (CDC)
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • National Institutes of Health (NIH)
      • National Institute of Allergy and Infectious Diseases (NIAID)
    • Office of the Assistant Secretary for Health (OASH)

  • Department of Defense (DoD)
    • Assistant Secretary of Defense for Health Affairs (Co-Chair)
    • Office of the Assistant Secretary of Defense for Homeland Defense and Global Security
    • Office of the Director of Defense Research and Engineering for Research and Technology

  • Department of Agriculture (USDA)
  • Department of Homeland Security (DHS)
  • Department of Justice (DoJ)
  • Department of Veterans Affairs (VA)
    • Veterans Health Administration (VHA)

The Task Force will develop an implementation plan to accomplish the strategic objectives in coordination with existing influenza vaccine related strategic plans. This implementation plan will identify activities and anticipated timelines, including activities that will be completed in the near-term (i.e., within five years). On an annual basis, the Task Force will assess progress towards achieving the vision outlined in the NIVMS. The Task Force will also help coordinate interagency efforts to promote an integrated and modernized influenza vaccine enterprise.